CHARACTERISTICS AND SURVIVAL RESULTS OF PERITONEAL DIALYSIS PATIENTS SUFFERING FROM COVID-19 IN TURKEY: A MULTICENTER NATIONAL STUDY

Background: We aimed to study the characteristics of peritoneal dialysis (PD) patients with Coronavirus disease-19 (COVID-19), determine the short-term mortality and other medical complications, and delineate the factors associated with COVID-19 outcome. Methods: In this multicenter national study,...

Full description

Bibliographic Details
Main Authors: Meltem Gursu, Savas Ozturk, Mustafa Arici, Idris Sahin, Sibel Gökçay Bek, Murvet Yilmaz, Sumeyra Koyuncu, Semahat Karahisar Şirali, Zeynep Ural, Belda Dursun, Enver Yuksel, Sami Uzun, Savaş Sipahi, Elbis Ahbap, Ayse Serra Artan, Orcun Altunoren, Onur Tunca, Yavuz Ayar, Ebru Gok-Oguz, Zulfukar Yilmaz, Serdar Kahvecioglu, Ebru Asicioglu, Aysegul Oruc, Mehmet Riza Altiparmak, Zeki Aydin, Bulent Huddam, Murside Esra Dolarslan, Alper Azak, Serkan Bakirdogen, Ahmet Ugur Yalcin, Serhat Karadag, Memnune Sena Ulu, Ozkan Gungor, Elif Ari Bakir, Ali Riza Odabas, Nurhan Seyahi, Alaattin Yildiz, Kenan Ates
Format: Article
Language:English
Published: Karger Publishers 2022-09-01
Series:Kidney & Blood Pressure Research
Online Access:https://www.karger.com/Article/FullText/526909
_version_ 1828133532118024192
author Meltem Gursu
Savas Ozturk
Mustafa Arici
Idris Sahin
Sibel Gökçay Bek
Murvet Yilmaz
Sumeyra Koyuncu
Semahat Karahisar Şirali
Zeynep Ural
Belda Dursun
Enver Yuksel
Sami Uzun
Savaş Sipahi
Elbis Ahbap
Ayse Serra Artan
Orcun Altunoren
Onur Tunca
Yavuz Ayar
Ebru Gok-Oguz
Zulfukar Yilmaz
Serdar Kahvecioglu
Ebru Asicioglu
Aysegul Oruc
Mehmet Riza Altiparmak
Zeki Aydin
Bulent Huddam
Murside Esra Dolarslan
Alper Azak
Serkan Bakirdogen
Ahmet Ugur Yalcin
Serhat Karadag
Memnune Sena Ulu
Ozkan Gungor
Elif Ari Bakir
Ali Riza Odabas
Nurhan Seyahi
Alaattin Yildiz
Kenan Ates
author_facet Meltem Gursu
Savas Ozturk
Mustafa Arici
Idris Sahin
Sibel Gökçay Bek
Murvet Yilmaz
Sumeyra Koyuncu
Semahat Karahisar Şirali
Zeynep Ural
Belda Dursun
Enver Yuksel
Sami Uzun
Savaş Sipahi
Elbis Ahbap
Ayse Serra Artan
Orcun Altunoren
Onur Tunca
Yavuz Ayar
Ebru Gok-Oguz
Zulfukar Yilmaz
Serdar Kahvecioglu
Ebru Asicioglu
Aysegul Oruc
Mehmet Riza Altiparmak
Zeki Aydin
Bulent Huddam
Murside Esra Dolarslan
Alper Azak
Serkan Bakirdogen
Ahmet Ugur Yalcin
Serhat Karadag
Memnune Sena Ulu
Ozkan Gungor
Elif Ari Bakir
Ali Riza Odabas
Nurhan Seyahi
Alaattin Yildiz
Kenan Ates
author_sort Meltem Gursu
collection DOAJ
description Background: We aimed to study the characteristics of peritoneal dialysis (PD) patients with Coronavirus disease-19 (COVID-19), determine the short-term mortality and other medical complications, and delineate the factors associated with COVID-19 outcome. Methods: In this multicenter national study, we included PD patients with confirmed COVID-19 from 27 centers. The baseline demographic, clinical, laboratory, and radiological data and outcomes at the end of the first month were recorded. Results: We enrolled 142 COVID-19 patients (median age:52 years). 58.2% of patients had mild disease at diagnosis. Lung involvement was detected in 60.8% of patients. 83 (58.4%) patients were hospitalized, 31 (21.8%) patients were admitted to intensive care unit and 24 needed mechanical ventilation. 15 (10.5%) patients were switched to hemodialysis and hemodiafiltration was performed for four (2.8%) patients. Persisting pulmonary symptoms (n=27), lower respiratory system infection (n=12), rehospitalization for any reason (n=24), malnutrition (n=6), hypervolemia (n=13), peritonitis (n=7), ultrafiltration failure (n=7) and in PD modality change (n=8) were reported in survivors. 26 patients (18.31%) died in the first month of diagnosis. The non-survivor group was older, comorbidities were more prevalent. Fever, dyspnea, cough, serious-vital disease at presentation, bilateral pulmonary involvement, and pleural effusion were more frequent among non-survivors. Age (OR:1.102; 95%CI: 1.032-1.117; p: 0.004), moderate-severe clinical disease at presentation (OR:26.825; 95%CI: 4.578-157.172; p<0.001) and baseline CRP (OR:1.008; 95%CI; 1.000-1.016; p:0.040) were associated with first-month mortality in multivariate analysis. Conclusions: Early mortality rate and medical complications are quite high in PD patients with COVID-19. Age, clinical severity of COVID-19, and baseline CRP level are the independent parameters associated with mortality.
first_indexed 2024-04-11T17:20:09Z
format Article
id doaj.art-669ac925543544e8b4943c61299b588b
institution Directory Open Access Journal
issn 1420-4096
1423-0143
language English
last_indexed 2024-04-11T17:20:09Z
publishDate 2022-09-01
publisher Karger Publishers
record_format Article
series Kidney & Blood Pressure Research
spelling doaj.art-669ac925543544e8b4943c61299b588b2022-12-22T04:12:30ZengKarger PublishersKidney & Blood Pressure Research1420-40961423-01432022-09-0110.1159/000526909526909CHARACTERISTICS AND SURVIVAL RESULTS OF PERITONEAL DIALYSIS PATIENTS SUFFERING FROM COVID-19 IN TURKEY: A MULTICENTER NATIONAL STUDYMeltem GursuSavas Ozturkhttps://orcid.org/0000-0002-0961-3810Mustafa Aricihttps://orcid.org/0000-0002-4055-7896Idris Sahinhttps://orcid.org/0000-0002-8683-3737Sibel Gökçay Bekhttps://orcid.org/0000-0003-3325-5993Murvet YilmazSumeyra KoyuncuSemahat Karahisar ŞiraliZeynep Uralhttps://orcid.org/0000-0002-3162-8760Belda DursunEnver Yukselhttps://orcid.org/0000-0003-0302-932XSami UzunSavaş SipahiElbis AhbapAyse Serra ArtanOrcun AltunorenOnur Tuncahttps://orcid.org/0000-0003-1958-7617Yavuz Ayarhttps://orcid.org/0000-0003-4607-9220Ebru Gok-OguzZulfukar YilmazSerdar KahveciogluEbru Asiciogluhttps://orcid.org/0000-0002-5685-115XAysegul Oruchttps://orcid.org/0000-0002-0342-9692Mehmet Riza AltiparmakZeki AydinBulent HuddamMurside Esra Dolarslanhttps://orcid.org/0000-0002-8669-4212Alper AzakSerkan Bakirdogenhttps://orcid.org/0000-0002-3448-0490Ahmet Ugur YalcinSerhat KaradagMemnune Sena UluOzkan Gungorhttps://orcid.org/0000-0003-1861-5452Elif Ari Bakirhttps://orcid.org/0000-0001-9208-7972Ali Riza Odabashttps://orcid.org/0000-0002-5248-1390Nurhan SeyahiAlaattin YildizKenan AtesBackground: We aimed to study the characteristics of peritoneal dialysis (PD) patients with Coronavirus disease-19 (COVID-19), determine the short-term mortality and other medical complications, and delineate the factors associated with COVID-19 outcome. Methods: In this multicenter national study, we included PD patients with confirmed COVID-19 from 27 centers. The baseline demographic, clinical, laboratory, and radiological data and outcomes at the end of the first month were recorded. Results: We enrolled 142 COVID-19 patients (median age:52 years). 58.2% of patients had mild disease at diagnosis. Lung involvement was detected in 60.8% of patients. 83 (58.4%) patients were hospitalized, 31 (21.8%) patients were admitted to intensive care unit and 24 needed mechanical ventilation. 15 (10.5%) patients were switched to hemodialysis and hemodiafiltration was performed for four (2.8%) patients. Persisting pulmonary symptoms (n=27), lower respiratory system infection (n=12), rehospitalization for any reason (n=24), malnutrition (n=6), hypervolemia (n=13), peritonitis (n=7), ultrafiltration failure (n=7) and in PD modality change (n=8) were reported in survivors. 26 patients (18.31%) died in the first month of diagnosis. The non-survivor group was older, comorbidities were more prevalent. Fever, dyspnea, cough, serious-vital disease at presentation, bilateral pulmonary involvement, and pleural effusion were more frequent among non-survivors. Age (OR:1.102; 95%CI: 1.032-1.117; p: 0.004), moderate-severe clinical disease at presentation (OR:26.825; 95%CI: 4.578-157.172; p<0.001) and baseline CRP (OR:1.008; 95%CI; 1.000-1.016; p:0.040) were associated with first-month mortality in multivariate analysis. Conclusions: Early mortality rate and medical complications are quite high in PD patients with COVID-19. Age, clinical severity of COVID-19, and baseline CRP level are the independent parameters associated with mortality.https://www.karger.com/Article/FullText/526909
spellingShingle Meltem Gursu
Savas Ozturk
Mustafa Arici
Idris Sahin
Sibel Gökçay Bek
Murvet Yilmaz
Sumeyra Koyuncu
Semahat Karahisar Şirali
Zeynep Ural
Belda Dursun
Enver Yuksel
Sami Uzun
Savaş Sipahi
Elbis Ahbap
Ayse Serra Artan
Orcun Altunoren
Onur Tunca
Yavuz Ayar
Ebru Gok-Oguz
Zulfukar Yilmaz
Serdar Kahvecioglu
Ebru Asicioglu
Aysegul Oruc
Mehmet Riza Altiparmak
Zeki Aydin
Bulent Huddam
Murside Esra Dolarslan
Alper Azak
Serkan Bakirdogen
Ahmet Ugur Yalcin
Serhat Karadag
Memnune Sena Ulu
Ozkan Gungor
Elif Ari Bakir
Ali Riza Odabas
Nurhan Seyahi
Alaattin Yildiz
Kenan Ates
CHARACTERISTICS AND SURVIVAL RESULTS OF PERITONEAL DIALYSIS PATIENTS SUFFERING FROM COVID-19 IN TURKEY: A MULTICENTER NATIONAL STUDY
Kidney & Blood Pressure Research
title CHARACTERISTICS AND SURVIVAL RESULTS OF PERITONEAL DIALYSIS PATIENTS SUFFERING FROM COVID-19 IN TURKEY: A MULTICENTER NATIONAL STUDY
title_full CHARACTERISTICS AND SURVIVAL RESULTS OF PERITONEAL DIALYSIS PATIENTS SUFFERING FROM COVID-19 IN TURKEY: A MULTICENTER NATIONAL STUDY
title_fullStr CHARACTERISTICS AND SURVIVAL RESULTS OF PERITONEAL DIALYSIS PATIENTS SUFFERING FROM COVID-19 IN TURKEY: A MULTICENTER NATIONAL STUDY
title_full_unstemmed CHARACTERISTICS AND SURVIVAL RESULTS OF PERITONEAL DIALYSIS PATIENTS SUFFERING FROM COVID-19 IN TURKEY: A MULTICENTER NATIONAL STUDY
title_short CHARACTERISTICS AND SURVIVAL RESULTS OF PERITONEAL DIALYSIS PATIENTS SUFFERING FROM COVID-19 IN TURKEY: A MULTICENTER NATIONAL STUDY
title_sort characteristics and survival results of peritoneal dialysis patients suffering from covid 19 in turkey a multicenter national study
url https://www.karger.com/Article/FullText/526909
work_keys_str_mv AT meltemgursu characteristicsandsurvivalresultsofperitonealdialysispatientssufferingfromcovid19inturkeyamulticenternationalstudy
AT savasozturk characteristicsandsurvivalresultsofperitonealdialysispatientssufferingfromcovid19inturkeyamulticenternationalstudy
AT mustafaarici characteristicsandsurvivalresultsofperitonealdialysispatientssufferingfromcovid19inturkeyamulticenternationalstudy
AT idrissahin characteristicsandsurvivalresultsofperitonealdialysispatientssufferingfromcovid19inturkeyamulticenternationalstudy
AT sibelgokcaybek characteristicsandsurvivalresultsofperitonealdialysispatientssufferingfromcovid19inturkeyamulticenternationalstudy
AT murvetyilmaz characteristicsandsurvivalresultsofperitonealdialysispatientssufferingfromcovid19inturkeyamulticenternationalstudy
AT sumeyrakoyuncu characteristicsandsurvivalresultsofperitonealdialysispatientssufferingfromcovid19inturkeyamulticenternationalstudy
AT semahatkarahisarsirali characteristicsandsurvivalresultsofperitonealdialysispatientssufferingfromcovid19inturkeyamulticenternationalstudy
AT zeynepural characteristicsandsurvivalresultsofperitonealdialysispatientssufferingfromcovid19inturkeyamulticenternationalstudy
AT beldadursun characteristicsandsurvivalresultsofperitonealdialysispatientssufferingfromcovid19inturkeyamulticenternationalstudy
AT enveryuksel characteristicsandsurvivalresultsofperitonealdialysispatientssufferingfromcovid19inturkeyamulticenternationalstudy
AT samiuzun characteristicsandsurvivalresultsofperitonealdialysispatientssufferingfromcovid19inturkeyamulticenternationalstudy
AT savassipahi characteristicsandsurvivalresultsofperitonealdialysispatientssufferingfromcovid19inturkeyamulticenternationalstudy
AT elbisahbap characteristicsandsurvivalresultsofperitonealdialysispatientssufferingfromcovid19inturkeyamulticenternationalstudy
AT ayseserraartan characteristicsandsurvivalresultsofperitonealdialysispatientssufferingfromcovid19inturkeyamulticenternationalstudy
AT orcunaltunoren characteristicsandsurvivalresultsofperitonealdialysispatientssufferingfromcovid19inturkeyamulticenternationalstudy
AT onurtunca characteristicsandsurvivalresultsofperitonealdialysispatientssufferingfromcovid19inturkeyamulticenternationalstudy
AT yavuzayar characteristicsandsurvivalresultsofperitonealdialysispatientssufferingfromcovid19inturkeyamulticenternationalstudy
AT ebrugokoguz characteristicsandsurvivalresultsofperitonealdialysispatientssufferingfromcovid19inturkeyamulticenternationalstudy
AT zulfukaryilmaz characteristicsandsurvivalresultsofperitonealdialysispatientssufferingfromcovid19inturkeyamulticenternationalstudy
AT serdarkahvecioglu characteristicsandsurvivalresultsofperitonealdialysispatientssufferingfromcovid19inturkeyamulticenternationalstudy
AT ebruasicioglu characteristicsandsurvivalresultsofperitonealdialysispatientssufferingfromcovid19inturkeyamulticenternationalstudy
AT ayseguloruc characteristicsandsurvivalresultsofperitonealdialysispatientssufferingfromcovid19inturkeyamulticenternationalstudy
AT mehmetrizaaltiparmak characteristicsandsurvivalresultsofperitonealdialysispatientssufferingfromcovid19inturkeyamulticenternationalstudy
AT zekiaydin characteristicsandsurvivalresultsofperitonealdialysispatientssufferingfromcovid19inturkeyamulticenternationalstudy
AT bulenthuddam characteristicsandsurvivalresultsofperitonealdialysispatientssufferingfromcovid19inturkeyamulticenternationalstudy
AT mursideesradolarslan characteristicsandsurvivalresultsofperitonealdialysispatientssufferingfromcovid19inturkeyamulticenternationalstudy
AT alperazak characteristicsandsurvivalresultsofperitonealdialysispatientssufferingfromcovid19inturkeyamulticenternationalstudy
AT serkanbakirdogen characteristicsandsurvivalresultsofperitonealdialysispatientssufferingfromcovid19inturkeyamulticenternationalstudy
AT ahmetuguryalcin characteristicsandsurvivalresultsofperitonealdialysispatientssufferingfromcovid19inturkeyamulticenternationalstudy
AT serhatkaradag characteristicsandsurvivalresultsofperitonealdialysispatientssufferingfromcovid19inturkeyamulticenternationalstudy
AT memnunesenaulu characteristicsandsurvivalresultsofperitonealdialysispatientssufferingfromcovid19inturkeyamulticenternationalstudy
AT ozkangungor characteristicsandsurvivalresultsofperitonealdialysispatientssufferingfromcovid19inturkeyamulticenternationalstudy
AT elifaribakir characteristicsandsurvivalresultsofperitonealdialysispatientssufferingfromcovid19inturkeyamulticenternationalstudy
AT alirizaodabas characteristicsandsurvivalresultsofperitonealdialysispatientssufferingfromcovid19inturkeyamulticenternationalstudy
AT nurhanseyahi characteristicsandsurvivalresultsofperitonealdialysispatientssufferingfromcovid19inturkeyamulticenternationalstudy
AT alaattinyildiz characteristicsandsurvivalresultsofperitonealdialysispatientssufferingfromcovid19inturkeyamulticenternationalstudy
AT kenanates characteristicsandsurvivalresultsofperitonealdialysispatientssufferingfromcovid19inturkeyamulticenternationalstudy